Investor euphoria in the cannabis sector reached a fever pitch this week as pot stocks went parabolic, producing gains of up to 238.89% in a span of just 3 days... read more →
In the Third-Quarter, Red White & Bloom Reported Quarter Over Quarter Revenue Growth of More Than 300% and a 69% Gross Margin Before Fair Value Impacts Considering RWB's Q3 Results... read more →
Canaccord Genuity Released a Comprehensive Research Report on MindMed Complete a with Bullish Buy Rating and Price Target The Leading Psychedelic Drug Development Company Also Submitted an Application to Uplist... read more →
Steve Grasso is a Regular on the Top-Rated CNBC Show "Fast Money" and Routinely Speaks at a Multitude of Investment Conferences Across the United States Fueled By Today's Announcement, Shares of... read more →
Champignon Brands Announces New Arrangement with Major Canadian Pharmacy Chain to Dispense the Firm's Ketamine Treatment The Company Also Announced the Successful Close of its Acquisition of Psychedelics Clinic Operator... read more →
Champignon Brands Selected as Headline Partner for Prohibition Partners' Upcoming Virtual Psychedelics Symposium Following Wednesday's Bullish Price Action, SHRM Stock Could Be in the Very Early Stages of Another Major... read more →
Champignon Brands Appoints Jay Kheita to the Company's Special Advisory Committee Mr. Kheita is a Founder of AltMed Capital Corp, a Leading Canadian Psychedelic Medicine Clinic Operator Since Last Week's... read more →
Psychedelics Stock Champignon Brands Soared 15% Today Officially Breaking Out of its Bullish Chart Formation Bull Pennants Are Continuation Patterns, Indicating SHRM's Current Uptrend is Highly Likely to Continue Shares... read more →
The Super-Undervalued U.S. Cannabis Sector is Leaving Canada in its Dust, and Profitable Firms are the Ones Leading the Pack The Timing is Right for a Bullish Announcement from Washington... read more →
Analysts Say U.S. MSOs Trulieve and Curaleaf Are a Buy With Upside of Up to 177% North of the Border, Cannabis 2.0 Sales Could Lift Shares of Valens and VIVO... read more →